aptam
nucleic
acidbas
ligand
identifi
process
molecular
evolut
name
selex
systemat
evolut
ligand
exponenti
enrich
last
year
numer
aptam
develop
specif
target
present
associ
surfac
human
cell
infecti
pathogen
virus
bacteria
fungi
parasit
sever
aptam
describ
potent
probe
rival
antibodi
use
flow
cytometri
microscopi
also
use
drug
inhibit
activ
function
target
manner
similar
neutral
agonist
antibodi
addit
straightforward
conjug
aptam
agent
without
lose
affin
success
use
vitro
vivo
deliv
drug
sirna
nanoparticl
contrast
agent
target
cell
henc
aptam
identifi
cell
surfac
biomark
repres
promis
class
ligand
review
present
differ
strategi
selex
develop
identifi
aptam
cell
surfaceassoci
protein
well
method
use
studi
bind
live
cell
larg
number
medic
biomark
express
surfac
human
cell
infecti
pathogen
virus
bacteria
fungi
parasit
composit
dynam
cell
surfac
determin
cell
pathogen
interact
environ
crucial
send
receiv
chemic
signal
transport
metabolit
ion
larger
molecul
attach
neighbor
cell
extracellular
matrix
etc
context
diseas
mutat
delet
overexpress
cell
surfac
protein
associ
mani
patholog
state
membran
protein
current
target
half
approv
drug
henc
high
demand
specif
ligand
cell
surfac
target
fundament
research
also
diagnosi
monitor
treatment
diseas
far
ligand
develop
protein
wherea
exist
carbohydr
lipid
two
type
ligand
develop
small
molecul
drug
predominantli
design
bind
intracellular
catalyt
domain
membran
protein
peptidebas
ligand
antibodi
design
bind
intracellular
extracellular
domain
among
exist
ligand
antibodi
extens
use
profil
express
cell
surfac
biomark
studi
role
antibodi
led
develop
cluster
differenti
cd
nomenclatur
initi
use
phenotyp
cell
immun
system
extend
mani
cell
type
http
howev
challeng
identifi
antibodi
recogn
membran
protein
exist
natur
environ
cell
surfac
inde
difficult
present
membran
protein
immun
system
nativ
conform
mani
target
standard
immun
approach
far
appli
limit
success
henc
wherea
predict
number
human
transmembran
protein
high
antibodi
identifi
cd
antigen
nucleic
acidbas
ligand
name
aptam
appear
appeal
new
ligand
field
one
hundr
aptam
select
cell
surfac
target
past
year
aptam
gener
molecular
direct
evolut
approach
librari
oligonucleotid
contain
region
random
base
composit
techniqu
usual
name
selex
systemat
evolut
ligand
exponenti
enrich
consist
repetit
cycl
select
amplif
figur
cycl
oligonucleotid
affin
desir
target
retain
amplifi
lead
enrich
pool
final
sequenc
identifi
aptam
sinc
strategi
use
identifi
aptam
wide
varieti
target
small
molecul
peptid
protein
nucleic
acidbas
structur
review
see
mani
case
aptam
shown
present
high
specif
affin
well
inhibitori
modulatori
activ
toward
target
moreov
seem
lack
immunogen
chemic
modifi
order
improv
stabil
nucleas
modifi
pharmacokinet
allow
label
due
uniqu
advantag
aptam
use
sever
applic
basic
appli
research
instanc
aptam
use
studi
natur
interact
rna
protein
regul
gene
express
develop
biosensor
purifi
specif
molecul
inhibit
function
protein
develop
drug
review
see
random
pool
oligonucleotid
candid
incub
target
purifi
cell
surfac
biomark
membran
extract
whole
live
cell
organ
sequenc
bind
target
remov
differ
partit
method
ex
affin
chromatographi
filtrat
centrifug
bound
sequenc
elut
ex
urea
edta
competit
ligand
amplifi
pcr
rtpcr
vitro
transcript
case
rna
librari
select
pool
enter
new
round
select
repetit
round
select
popul
evolv
toward
sequenc
best
affin
target
end
process
sequenc
clone
sequenc
identifi
aptam
aptam
recogn
threedimension
structur
target
high
specif
affin
often
highli
depend
chosen
condit
appli
select
therefor
import
perform
selex
nativ
conform
target
much
possibl
near
natur
environ
condit
easili
provid
solubl
target
difficult
achiev
membran
protein
whose
structur
inextric
link
inclus
lipid
bilay
well
interact
intraand
extracellular
matrix
although
sever
aptam
success
select
purifi
cell
surfac
carbohydr
recombin
ectodomain
membran
protein
threedimension
structur
purifi
cell
surfac
biomark
rather
differ
one
found
context
plasma
membran
therefor
aptam
select
purifi
domain
membran
protein
sometim
unabl
bind
natur
protein
express
cell
surfac
bypass
drawback
sever
new
method
selex
develop
allow
aptam
select
condit
close
possibl
natur
situat
figur
present
review
describ
differ
strategi
develop
select
aptam
cell
surfac
biomark
first
selex
membran
protein
perform
lselectin
nexstar
pharmaceut
inc
boulder
co
usa
lselectin
calciumdepend
cell
surfac
lectin
constitut
express
leukocyt
mediat
adhes
endotheli
cell
interact
cellspecif
carbohydr
pool
nucleasestabil
rna
librari
select
human
lselectinig
chimera
immobil
protein
asepharos
bead
extens
wash
bound
oligonucleotid
elut
mm
edta
selex
identifi
aptam
high
affin
much
lower
affin
isol
aptam
improv
thermal
stabil
group
perform
selex
higher
select
temperatur
either
use
dna
librari
result
highlight
aptam
select
close
possibl
physiolog
condit
ie
order
potenti
usabl
vivo
two
year
later
selex
perform
full
length
extracellular
domain
produc
mammalian
express
system
immobil
bead
remov
sequenc
abil
bind
site
select
matrix
librari
round
select
preexpos
bead
lack
furthermor
two
type
bead
use
select
first
six
round
perform
biotinyl
captur
bead
coat
streptavidin
subsequ
anoth
six
round
perform
captur
onto
bead
coat
monoclon
antibodi
interestingli
select
aptam
abl
bind
recombin
ectodomain
also
entir
protein
express
surfac
mous
cell
line
transfect
contrast
measur
bind
observ
nontransfect
cell
line
lack
express
henc
aptam
select
purifi
ectodomain
membran
protein
may
also
abl
recogn
protein
nativ
environ
similar
selex
experi
perform
success
type
membran
protein
includ
g
protein
coupledreceptor
gpcr
receptor
tyrosin
kinas
rtk
tumour
necrosi
factor
tnf
receptor
see
tabl
addit
similar
strategi
also
appli
select
aptam
protein
surfac
bacteria
parasit
well
envelop
capsid
virus
see
tabl
aptam
select
target
cell
surfaceassoci
carbohydr
repres
import
class
cell
surfac
biomark
well
first
anticarbohydr
aptam
select
sialyl
lewi
x
slex
known
ligand
selectin
protein
overexpress
surfac
sever
type
tumor
cell
select
aptam
high
affin
k
around
target
similar
lewi
group
sugar
contrast
demonstr
time
lower
affin
unrel
sugar
lactos
carbohydr
often
anion
could
repres
limit
select
aptam
neg
charg
solv
problem
chemic
modifi
aptam
develop
contain
cation
proton
amino
group
posit
thymidin
strategi
appli
success
identifi
aptam
sialyllactos
strongli
anion
classic
selex
purifi
solubl
protein
differ
method
use
partit
sequenc
affin
target
rest
pool
see
tabl
gopinath
et
al
review
differ
method
case
select
aptam
perform
ectodomain
protein
immobil
support
magnet
bead
plastic
plate
spr
biosensor
product
purif
membran
protein
ectodomain
often
much
easier
whole
protein
furthermor
ectodomain
higher
chanc
conserv
proper
fold
outsid
lipid
bilay
howev
case
aptam
identifi
use
strategi
unabl
bind
target
nativ
form
environ
cell
surfac
tabl
instanc
aptam
select
ectodomain
egfrviii
protein
produc
e
coli
unabl
bind
target
produc
eukaryot
system
possess
posttransl
modif
work
demonstr
glycosyl
state
protein
crucial
aspect
consid
use
recombin
purifi
protein
target
selex
howev
use
glycosyl
purifi
ectodomain
still
guaranti
obtain
aptam
nativ
form
instanc
found
group
aptam
select
glycosyl
ectodomain
ret
transmembran
receptor
unabl
bind
target
surfac
cell
although
purifi
ectodomain
confirm
bind
natur
ligand
gdnf
result
demonstr
case
aptam
select
purifi
ectodomain
protein
may
unabl
bind
target
express
surfac
cell
even
purifi
ectodomain
display
glycosyl
pattern
function
similar
nativ
protein
solv
problem
new
selex
procedur
develop
order
select
aptam
membran
protein
physiolog
environ
selex
perform
directli
purifi
plasma
membran
see
tabl
howev
case
aptam
select
conduct
toward
mixtur
target
present
plasma
membran
first
selex
complex
mixtur
target
perform
use
human
red
blood
cell
rbc
ghost
round
select
use
filtrat
method
recov
sequenc
bound
rbc
membran
aptam
high
affin
rbc
identifi
uvcrosslink
experi
demonstr
kind
selex
result
aptam
sever
differ
membran
protein
howev
drawback
approach
target
aptam
least
initi
unknown
direct
selex
target
interest
specif
elut
aptam
use
natur
ligand
target
propos
approach
use
select
aptam
sever
receptor
nervou
system
use
membran
extract
brain
homogen
rat
californica
electr
organ
cell
line
express
glutam
receptor
channel
tabl
select
bound
aptam
elut
use
ligand
receptor
remov
unbound
aptam
filtrat
addit
select
aptam
specif
target
strategi
also
result
aptam
potent
competitor
natur
ligand
receptor
although
protein
plasma
membran
extract
physiolog
environ
compar
purifi
ectodomain
well
known
plasma
membran
dynam
system
compos
membran
constitu
close
contact
well
intraandor
extracellular
matrix
therefor
sever
group
gone
one
step
appli
selex
directli
whole
live
function
biolog
system
see
tabl
kind
selex
perform
first
time
trypanosoma
brucei
parasit
bacillu
anthraci
spore
case
partit
bound
unbound
sequenc
done
centrifug
parasit
bacteria
spore
interestingli
selex
trypanosoma
brucei
result
type
aptam
spite
numer
potenti
target
present
surfac
parasit
suggest
exist
domin
epitop
aptam
predominantli
select
target
specif
local
flagellar
pocket
trypanosom
aptam
select
vsg
protein
abund
polypeptid
trypanosom
surfac
selex
perform
human
cytomegaloviru
use
filtrat
case
aptam
predominantli
select
glycoprotein
b
h
repres
abund
expos
envelop
protein
viru
selex
perform
first
time
whole
live
mammalian
cell
line
selex
librari
counterselect
round
microgli
cell
select
rat
endotheli
cell
two
cell
type
nonadh
cell
unbound
sequenc
remov
centrifug
counterselect
perform
favour
aptam
target
whose
express
link
endotheli
phenotyp
pool
fluoresc
label
selex
allow
monitor
enrich
cellbind
aptam
use
flow
cytometri
sequenc
individu
sequenc
test
show
affin
ec
cell
line
flow
cytometri
could
bind
microvessel
cryostat
tissu
section
rat
brain
glioblastoma
sinc
sever
aptam
select
conduct
live
cell
strategi
name
cellselex
centrifug
partit
method
choic
nonadher
cell
case
adher
cell
gentl
plate
wash
use
howev
recent
anoth
method
describ
raddatz
et
al
use
fluorescenceactiv
cell
sort
fac
perform
partit
bound
unbound
sequenc
studi
demonstr
fac
power
method
select
aptam
live
burkitt
lymphoma
b
cell
particularli
allow
elimin
dead
cell
usual
display
high
nonspecif
bind
nucleic
acid
rna
brucei
nd
mention
previous
selex
membran
compart
selex
live
biolog
system
often
also
result
identif
aptam
unknown
target
difficult
identifi
unknown
target
aptam
open
new
avenu
applic
selex
within
biomark
identif
cell
phenotyp
exampl
subtract
cellbas
method
describ
selex
endotheli
cell
line
allow
identif
aptam
target
differenti
express
differ
cell
type
furthermor
aptam
also
select
abil
distinguish
cell
basi
differenti
state
distinguish
cancer
cell
viru
infect
cell
normal
cell
origin
discrimin
instanc
differ
lineag
hematopoiet
cancer
see
tabl
aptam
target
identif
lead
identif
valid
cell
specif
biomark
strategi
name
aptabid
aptamerfacil
biomark
discoveri
sever
protocol
use
isol
identifi
target
protein
aptam
select
use
cellselex
basic
affin
chromatographi
perform
use
biotinyl
aptam
preincub
membran
protein
extract
total
protein
extract
altern
live
cell
follow
cell
lysi
bound
protein
subsequ
recov
separ
sdspage
electrophoresi
identifi
mass
spectrometri
differ
strategi
develop
select
aptam
specif
cell
surfac
target
use
live
organ
cell
previous
describ
selex
purifi
plasma
membran
displac
aptam
use
ligand
known
biomark
use
exampl
isol
aptam
cell
surfac
protein
cruzi
interact
host
cellular
matrix
compon
cell
surfac
protein
extracellular
matrix
bind
parasit
surfac
affect
host
cell
invas
select
aptam
parasit
aptam
elut
perform
use
mix
protein
extracellular
matrix
includ
laminin
fibronectin
heparan
sulfat
thrombospondin
order
isol
high
affin
aptam
abil
compet
host
cell
matrix
molecul
bind
cruzi
cell
surfac
furthermor
select
aptam
specif
infect
form
parasit
counterselect
step
use
noninfect
epimastigot
surfac
appli
round
seven
selex
experi
group
develop
strategi
select
aptam
specif
cell
surfac
target
use
transfect
cell
overexpress
protein
interest
valid
approach
select
aptam
transfect
cell
overexpress
human
mutat
receptor
tyrosin
kinas
ret
ret
constitut
activ
dimer
form
round
perform
counterselect
step
mocktransfect
cell
cell
overexpress
monomer
activ
mutant
ret
ret
use
strategi
abl
identifi
aptam
inhibit
ret
dimerizationdepend
signal
pathway
induc
either
natur
ligand
gdnf
activ
mutat
howev
aptam
distinguish
dimer
form
ret
monom
form
spite
counterselect
use
ret
express
cell
furthermor
repres
minor
select
sequenc
sequenc
similar
strategi
also
use
identifi
aptam
transform
growth
type
iii
tbriii
envelop
glycoprotein
altern
aptam
select
use
known
overexpress
membran
protein
counterselect
use
cell
line
treat
sirna
anoth
strategi
involv
immunoprecipit
step
develop
select
aptam
tolllik
receptor
studi
tolllik
receptor
fuse
fc
fragment
transient
express
cell
dna
librari
incub
whole
cell
lysi
directli
cell
lysat
sequenc
specif
bound
receptor
recov
use
protein
bead
comparison
selex
purifi
target
select
aptam
complex
mixtur
target
exampl
cellselex
difficult
direct
toward
specif
protein
howev
latter
case
membran
protein
environ
close
nativ
situat
compil
advantag
type
selex
method
crossov
strategi
develop
shift
step
selex
purifi
protein
cell
express
protein
perform
aptam
tenascinc
obtain
use
kind
strategi
nine
round
cellselex
two
round
perform
purifi
protein
improv
affin
pool
protein
group
show
strategi
allow
higher
specif
enrich
aptam
ret
cellselex
alon
select
aptam
use
pure
wholeliv
cellselex
display
better
appar
k
recent
crossov
selex
use
obtain
aptam
direct
protein
nine
round
perform
purifi
protein
five
round
cell
overexpress
protein
interest
aptam
found
bind
purifi
protein
wherea
two
bound
recombin
jurkat
nk
cell
one
aptam
alreadi
present
end
select
purifi
protein
wherea
present
popul
select
purifi
protein
cell
overexpress
aptam
select
receptor
anoth
strategi
appli
involv
shift
select
plasma
membran
extract
contain
membran
protein
select
purifi
form
insert
immobil
artifici
membran
iam
iam
use
previous
immobil
variou
type
transmembran
protein
includ
transport
carrier
receptor
case
protein
retain
abil
bind
ligand
setup
iam
could
use
determin
pharmacolog
properti
three
initi
cycl
selex
use
plasma
membran
prepar
contain
receptor
pool
load
column
chromatograph
select
rna
molecul
bind
affin
receptor
one
round
iam
chromatographi
selex
abl
improv
affin
pool
receptor
recent
selex
perform
directli
cancer
tissu
li
et
al
perform
selex
paraffinembed
tissu
section
infiltr
ductal
carcinoma
counterselect
adjac
normal
tissu
case
advantag
method
possibl
select
aptam
fraction
tissu
includ
extracellular
matrix
membran
compon
intracellular
target
one
aptam
identifi
specif
recogn
breast
cancer
cell
clinic
tissu
section
differ
patholog
type
breast
cancer
cell
line
target
aptam
identifi
intracellular
protein
hnrnp
mention
previous
cellselex
perform
identifi
aptam
specif
cell
surfac
biomark
diseas
without
prior
knowledg
marker
howev
question
remain
whether
cell
cultur
relev
model
diseas
purpos
adapt
selex
procedur
complet
physiolog
environ
selex
recent
perform
vivo
select
aptam
recogn
intrahepat
colorect
cancer
metastasi
fpi
rna
librari
inject
intraven
mous
bear
previous
implant
hepat
tumour
liver
tumour
collect
rna
subsequ
extract
amplifi
new
popul
fpi
rna
reinject
new
mous
process
repeat
sever
time
interestingli
evolv
rna
pool
demonstr
higher
affin
tumour
protein
extract
normal
colon
cell
protein
extract
popul
round
clone
sequenc
interestingli
target
one
aptam
determin
intracellular
rna
helicas
known
upregul
colorect
cancer
whatev
selex
method
use
sequenc
pool
bind
individu
aptam
clone
evalu
live
organ
cell
evalu
affin
aptam
determin
also
specif
target
sinc
found
mix
mani
biomark
cell
surfac
sever
strategi
present
measur
bind
aptam
live
cell
basic
aptam
incub
cell
differ
concentr
bound
aptam
quantifi
extens
wash
use
scatchard
analysi
k
cmax
appar
concentr
target
cell
surfac
measur
specif
cell
line
cell
adher
possibl
incub
cell
radiolabel
aptam
follow
wash
step
detect
bound
aptam
scintil
count
cell
nonadh
mani
studi
appli
fluoresc
aptam
perform
similar
analys
flow
cytometri
latter
techniqu
also
appli
tool
monitor
progress
cellselex
experi
techniqu
also
use
adher
cell
cell
put
suspens
flow
cytometri
analysi
howev
presenc
protein
plasma
membran
may
affect
procedur
associ
detach
adher
cell
solid
support
cultur
plate
instanc
li
et
al
demonstr
aptam
tenascinc
good
probe
flow
cytometri
analysi
use
glioma
cell
wherea
label
cell
effici
adhes
use
microscopi
tenascinc
extracellular
matrix
glycoprotein
author
hypothes
protein
may
remov
degrad
process
detach
use
trypsin
perform
prior
flow
cytometri
analysi
past
year
grow
number
report
describ
identif
aptam
cell
surfaceassoci
target
time
sever
differ
strategi
perform
selex
also
develop
enabl
select
aptam
particularli
membran
protein
nearphysiolog
condit
advanc
strategi
increas
probabl
select
aptam
membran
target
nativ
form
natur
environ
cell
surfac
howev
new
selex
method
alway
straightforward
compar
classic
selex
method
purifi
target
henc
pitfal
cellselex
describ
caus
failur
select
process
instanc
presenc
dead
cell
select
captur
nonspecif
high
number
oligonucleotid
counterselect
alway
effici
purif
dna
singl
strand
use
streptavidin
bead
imperfect
furthermor
vivo
selex
small
anim
tissu
slidebas
selex
yet
reproduc
two
year
publish
first
time
eventhough
selex
method
particularli
promis
nevertheless
new
method
expect
improv
next
decad
lead
select
mani
aptam
cell
surfac
target
aptam
potenti
use
sever
applic
instanc
aptam
bind
membran
protein
involv
diseas
often
inhibit
activ
target
lead
develop
new
drug
exampl
neutral
antinucleolin
aptam
current
phase
iib
clinic
trial
treatment
acut
myeloid
leukemia
aml
combin
cytarabin
addit
aptam
target
cell
surfac
protein
success
use
target
moieti
deliv
contrast
agent
nanoparticl
encapsul
drug
sirna
specif
tissu
vivo
furthermor
use
within
develop
diagnost
assay
field
cancer
infecti
diseas
food
safeti
bioterror
final
recent
area
interest
aptam
select
membran
protein
use
method
cellselex
within
cell
surfac
biomark
discoveri
cell
phenotyp
consequ
select
aptam
cell
surfac
biomark
high
potenti
use
fundament
research
also
diagnosi
monitor
treatment
diseas
